Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports
Go Back
View Our Subscription Options

Search

Descriptive Alt Text

Filters

Showing results 1,249–1,256 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Celldex Therapeutics Inc. Barzolvolimab (CDX-0159) Chronic spontaneous urticaria (CSU) Phase 2 Data Released Intravenous Immunology
Celldex Therapeutics Inc. CDX-3379 Recurrent/metastatic head and neck squamous cell cancer Phase 2 Trial Discontinued Intravenous Oncology
Celldex Therapeutics Inc. Barzolvolimab - (EMBARQ-ColdU and SD) Cold urticaria (ColdU) and symptomatic dermographism (SD) Phase 3 Enrollment Initiation Subcutaneous Immunology
Celldex Therapeutics Inc. Barzolvolimab (CDX-0159) - (EMBARQ-CSU1) Chronic Spontaneous Urticaria (CSU) Phase 3 Trial Planned Intravenous Immunology
Celldex Therapeutics Inc. Barzolvolimab (CDX-0159) - (EMBARQ-CSU2) Chronic Spontaneous Urticaria (CSU) Phase 3 Trial Planned Intravenous Immunology
Celldex Therapeutics Inc. Barzolvolimab (CDX-0159) Chronic Inducible Urticaria Phase 2 Trial Planned Intravenous Immunology
Celldex Therapeutics Inc. Glembatumumab vedotin Metastatic triple negative breast cancers that overexpress gpNMB Phase 2b Trial Discontinued Intravenous Oncology
Cellectar Biosciences Inc. CLR 131 - (CLOVER-1) Various lymphoma Phase 2 Ongoing Intravenous Oncology
1…155156157158159…553
Your trusted source for drug reimbursement data and buy-and-bill insights.
Platform
Resources
Tools
Search Drugs
Newsletter
Reimbursement updates, drug pricing news.
© 2026 BuyandBill.com, All Rights Reserved.
HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, America's Health Insurance Plans, and Blue Cross and Blue Shield Association). CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.